Suppr超能文献

米佐拉姆邦佐拉姆医学院新冠肺炎死亡率概述:一项基于医院的研究。

Overview of COVID-19 mortality in Zoram Medical College, Mizoram: A hospital-based study.

作者信息

Laltlanzovi C, Vankhuma C, Chhakchhuak Diana Lalrinsiami, Zothanzauva J C

机构信息

Department of Pathology and Co-Principal Investigator of ICMR-NCDIR e-Mor Project, Zoram Medical College, Falkawn, Mizoram, India.

Department of Community Medicine and Principal Investigator, ICMR-NCDIR e-Mor Project, Zoram Medical College, Falkawn, Mizoram, India.

出版信息

J Family Med Prim Care. 2023 Feb;12(2):253-258. doi: 10.4103/jfmpc.jfmpc_1251_22. Epub 2023 Feb 28.

Abstract

BACKGROUND

Mizoram is a small state in the northeastern part of India and recorded its first case of coronavirus disease 2019 (COVID-19) on March 24, 2020. The first registered death because of COVID-19 in the state was on October 28, 2020 at Zoram Medical College (ZMC), which is a dedicated COVID hospital in Mizoram. COVID-19 cases from different districts in the state were referred to ZMC according to severity of symptoms. NCDIR-ICMR e-Mortality Cell was first started as a project at ZMC in 2019. Since then, all hospital deaths are recorded using a structured questionnaire developed by NCDIR which has also strengthened the data for COVID-19 mortality statistics in the state. The objective of this study is to determine the association of in-hospital COVID-19 mortality in relation to age, sex, vaccine status, and underlying co-morbidities and highlight the utility of ICMR-NCDIR e-Mortality software in the hospital.

METHODS

Data on COVID-19-associated deaths from October 2020 to October 2021 at ZMC were collected from the hospital e-Mortality software and Medical Records Department (MRD). This includes patients' demographic characteristics including age, sex, vaccination status, and underlying co-morbidities if any. Appropriate statistical analysis was performed to evaluate the correlation between variables.

RESULTS

From October 2020 to October 2021, a total of 324 deaths related to COVID-19 was recorded at ZMC, Mizoram. The majority of the deaths were distributed in the age group 65 years and above and accounts for 49.1% in all age groups. Out of the total deaths, 64.2% (208) were males and 81.48% had an associated underlying co-morbidity besides COVID-19. The most common co-morbidities were hypertension, type 2 diabetes mellitus, cancer, and chronic obstructive pulmonary disease. More than half, 59.6%, had no vaccination history, and all the cases had no history of taking a booster vaccination dose. A statistically significant correlation between delay in time to admission and length of hospital stay (p = 0.017) was also seen.

CONCLUSIONS

COVID-19 is more severe in the older age group above 65 years of age and in males, particularly in the presence of underlying co-morbidities. Mortality was also higher in patients with no history of vaccination as compared with patients vaccinated. Also, delay in hospital admission increases the length of hospital stay and mortality.

摘要

背景

米佐拉姆邦是印度东北部的一个小邦,于2020年3月24日记录了首例2019冠状病毒病(COVID-19)病例。该邦首例因COVID-19登记的死亡病例于2020年10月28日发生在佐拉姆医学院(ZMC),这是米佐拉姆邦一家专门的COVID医院。该邦不同地区的COVID-19病例根据症状严重程度被转诊至ZMC。NCDIR-ICMR电子死亡监测小组于2019年在ZMC首次作为一个项目启动。从那时起,所有医院死亡病例都使用NCDIR开发的结构化问卷进行记录,这也加强了该邦COVID-19死亡率统计的数据。本研究的目的是确定住院COVID-19死亡率与年龄、性别、疫苗接种状况和潜在合并症之间的关联,并强调ICMR-NCDIR电子死亡监测软件在医院中的实用性。

方法

从医院电子死亡监测软件和病历部(MRD)收集了2020年10月至2021年10月ZMC与COVID-19相关死亡病例的数据。这包括患者的人口统计学特征,如年龄、性别、疫苗接种状况以及是否存在潜在合并症。进行了适当的统计分析以评估变量之间的相关性。

结果

2020年10月至2021年10月,米佐拉姆邦ZMC共记录了324例与COVID-19相关的死亡病例。大多数死亡病例分布在65岁及以上年龄组,占所有年龄组的49.1%。在所有死亡病例中,64.2%(208例)为男性,81.48%除COVID-19外还伴有潜在合并症。最常见的合并症是高血压、2型糖尿病、癌症和慢性阻塞性肺疾病。超过一半(59.6%)的患者没有疫苗接种史,所有病例均无接种加强针的历史。入院时间延迟与住院时间之间也存在统计学显著相关性(p = 0.017)。

结论

COVID-19在65岁以上的老年人群和男性中更为严重,尤其是在存在潜在合并症的情况下。与接种疫苗的患者相比,未接种疫苗史的患者死亡率也更高。此外,延迟入院会增加住院时间和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762c/10114571/7d0950b54ed2/JFMPC-12-253-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验